ReP USP - Resultado da busca

Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 16 nov. 2024.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women (2020)
Benzi, Jhohann Richard de Lima ; Moreira, Fernanda de Lima; Marques, Maria Paula ; Duarte, Geraldo; Suarez-Kurtz, Guilherme; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: LÍQUIDOS CORPORAIS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, CITOCROMO P-450, INFECÇÕES POR HIV, CORTISOL, ESPECTROMETRIA DE MASSAS, FENÓTIPOS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENZI, Jhohann Richard de Lima et al. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, v. 1144 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2020.122074. Acesso em: 16 nov. 2024.
APA
Benzi, J. R. de L., Moreira, F. de L., Marques, M. P., Duarte, G., Suarez-Kurtz, G., & Lanchote, V. L. (2020). A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, 1144 . doi:10.1016/j.jchromb.2020.122074
NLM
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Vancouver
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Artigo de periodico
Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer (2019)
Souza, Marília Cristina Oliveira; Marques, Maria Paula; Duarte, Geraldo; Lanchote, Vera Lúcia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Assunto: ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 268-275, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.040. Acesso em: 16 nov. 2024.
APA
Souza, M. C. O., Marques, M. P., Duarte, G., & Lanchote, V. L. (2019). Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, 164, 268-275. doi:10.1016/j.jpba.2018.10.040
NLM
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Vancouver
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Artigo de periodico
Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis (2019)
Arroyo, Gianfranco; Bustos, Javier A.; Lescano, Andres G.; Gonzales, Isidro; Saavedra, Herbert; Rodriguez, Silvia; Pretell, E. Javier; Bonato, Pierina Sueli; Lanchote, Vera Lucia ; Takayanagui, Osvaldo Massaiti ; Horton, John; Gonzalez, Armando E.; Gilman, Robert H.; Garcia, Hector H.
Source: Clinical Infectious Diseases. Unidades: FCFRP, FMRP
Subjects: NEUROCISTICERCOSE, ANTIPARASITÁRIOS, ANTI-HELMÍNTICOS, CISTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARROYO, Gianfranco et al. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, v. 69, n. 11, p. 1996-2002, 2019Tradução . . Disponível em: https://doi.org/10.1093/cid/ciz085. Acesso em: 16 nov. 2024.
APA
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., et al. (2019). Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, 69( 11), 1996-2002. doi:10.1093/cid/ciz085
NLM
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/cid/ciz085
Vancouver
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/cid/ciz085
Artigo de periodico
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
Costa, A. C. C.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia; Correia, B. V.; Abumansur, Juliana Trench; Lauretti, Gabriela Rocha; Moraes, N. V. de
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOGENÉTICA, FARMACOCINÉTICA, POLIMORFISMO, BLOQUEIO NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. C. C. et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, v. 73, n. 8, p. 957-963, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00228-017-2243-1. Acesso em: 16 nov. 2024.
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Artigo de periodico
Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients (2016)
Godoy, Ana Leonor Pardo Campos; Rocha, Adriana; Souza, Cacilda da Silva; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: METABOLISMO, FARMACOCINÉTICA, PSORÍASE, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, v. 56, n. 5, p. 567-575, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.630. Acesso em: 16 nov. 2024.
APA
Godoy, A. L. P. C., Rocha, A., Souza, C. da S., & Lanchote, V. L. (2016). Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, 56( 5), 567-575. doi:10.1002/jcph.630
NLM
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.630
Vancouver
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.630
Artigo de periodico
Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women (2015)
Filgueira, Gabriela Campos de Oliveira; Filgueira, Osmany Alberto Silva; Carvalho, Daniela Miarelli; Marques, Maria Paula; Moisés, Elaine Christine Dantas; Duarte, Geraldo; Lanchote, Vera Lúcia; Cavalli, Ricardo de Carvalho
Source: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, GRAVIDEZ, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, v. 993-994, p. 20-25, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.04.030. Acesso em: 16 nov. 2024.
APA
Filgueira, G. C. de O., Filgueira, O. A. S., Carvalho, D. M., Marques, M. P., Moisés, E. C. D., Duarte, G., et al. (2015). Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 993-994, 20-25. doi:10.1016/j.jchromb.2015.04.030
NLM
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Vancouver
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Artigo de periodico
Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study (2013)
Antunes, Natalicia de Jesus; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Pasqua, Oscar Della; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaiti; Tozatto, Eduardo; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS PSICOTRÓPICOS, FARMACOCINÉTICA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalicia de Jesus et al. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study. Chirality, v. 25, n. 12, p. 897-903, 2013Tradução . . Disponível em: https://doi.org/10.1002/chir.22231. Acesso em: 16 nov. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Junior, V., Takayanagui, O. M., et al. (2013). Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study. Chirality, 25( 12), 897-903. doi:10.1002/chir.22231
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Lanchote VL. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study [Internet]. Chirality. 2013 ; 25( 12): 897-903.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.22231
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Lanchote VL. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study [Internet]. Chirality. 2013 ; 25( 12): 897-903.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.22231
Artigo de periodico
Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics (2011)
Godoy, Ana Leonor Pardo Campos; Moraes, Natália Valadares de; Martinez, Edson Zangiacomi; Carvalho, Teresa Maria de Jesus Ponte; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: ESPECTROMETRIA DE MASSAS, FARMACOCINÉTICA, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics. Chirality, v. 23, n. 4, p. 287-293, 2011Tradução . . Disponível em: https://doi.org/10.1002/chir.20914. Acesso em: 16 nov. 2024.
APA
Godoy, A. L. P. C., Moraes, N. V. de, Martinez, E. Z., Carvalho, T. M. de J. P., Marques, M. P., & Lanchote, V. L. (2011). Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics. Chirality, 23( 4), 287-293. doi:10.1002/chir.20914
NLM
Godoy ALPC, Moraes NV de, Martinez EZ, Carvalho TM de JP, Marques MP, Lanchote VL. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics [Internet]. Chirality. 2011 ; 23( 4): 287-293.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.20914
Vancouver
Godoy ALPC, Moraes NV de, Martinez EZ, Carvalho TM de JP, Marques MP, Lanchote VL. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics [Internet]. Chirality. 2011 ; 23( 4): 287-293.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.20914
Artigo de periodico
Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery (2007)
Tirapelli, Carlos Renato ; Casolari, Débora A.; Yogi, Álvaro; Passaglia, Rita de Cássia Aleixo Tostes; Legros, Eurode; Lanchote, Vera Lúcia; Uyemura, Sérgio Akira; Oliveira, Ana Maria de
Source: Alcohol. Unidades: ICB, FCFRP
Subjects: ÁLCOOL, ARTÉRIAS CARÓTIDAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIRAPELLI, Carlos Renato et al. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol, v. 41, n. 2, p. 77-85, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.alcohol.2007.02.004. Acesso em: 16 nov. 2024.
APA
Tirapelli, C. R., Casolari, D. A., Yogi, Á., Passaglia, R. de C. A. T., Legros, E., Lanchote, V. L., et al. (2007). Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol, 41( 2), 77-85. doi:10.1016/j.alcohol.2007.02.004
NLM
Tirapelli CR, Casolari DA, Yogi Á, Passaglia R de CAT, Legros E, Lanchote VL, Uyemura SA, Oliveira AM de. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery [Internet]. Alcohol. 2007 ; 41( 2): 77-85.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.alcohol.2007.02.004
Vancouver
Tirapelli CR, Casolari DA, Yogi Á, Passaglia R de CAT, Legros E, Lanchote VL, Uyemura SA, Oliveira AM de. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery [Internet]. Alcohol. 2007 ; 41( 2): 77-85.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.alcohol.2007.02.004

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation